应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RGLS Regulus Therapeutics Inc
盘后交易 04-30 16:17:57 EDT
7.98
+4.61
+136.80%
盘后
7.93
-0.05
-0.63%
16:17 EDT
最高
8.20
最低
7.70
成交量
2,849万
今开
7.99
昨收
3.37
日振幅
14.84%
总市值
5.29亿
流通市值
3.58亿
总股本
6,624万
成交额
2.25亿
换手率
63.50%
流通股本
4,487万
市净率
6.92
ROE
-95.00%
每股收益
-0.82
52周最高
8.20
52周最低
0.8301
市盈率
-9.70
股息
0.00
股息收益率
0.00
ROA
-54.42%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Jones Trading:下调Regulus Therapeutics评级,由买入调整至持有评级, 目标价由8.00美元调整至7.00美元。
金融界 · 17:51
Jones Trading:下调Regulus Therapeutics评级,由买入调整至持有评级, 目标价由8.00美元调整至7.00美元。
加拿大投资银行集团:下调Regulus Therapeutics(RGLS.US)评级,由买入调整至持有评级, 目标价由28.00美元调整至11.00美元。
金融界 · 17:51
加拿大投资银行集团:下调Regulus Therapeutics(RGLS.US)评级,由买入调整至持有评级, 目标价由28.00美元调整至11.00美元。
Regulus Therapeutics暴涨,诺华拟斥资至多17亿美元收购该公司
老虎资讯综合 · 13:45
Regulus Therapeutics暴涨,诺华拟斥资至多17亿美元收购该公司
Regulus Therapeutics Inc.盘中异动 早盘大幅下挫5.01%报3.32美元
市场透视 · 04-29 15:12
Regulus Therapeutics Inc.盘中异动 早盘大幅下挫5.01%报3.32美元
Regulus Therapeutics Inc.盘中异动 快速拉升7.84%
市场透视 · 04-24
Regulus Therapeutics Inc.盘中异动 快速拉升7.84%
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.84%报2.46美元
市场透视 · 04-23
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.84%报2.46美元
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.42%
市场透视 · 04-22
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.42%
Regulus Therapeutics Inc.盘中异动 早盘急速上涨5.23%
市场透视 · 04-15
Regulus Therapeutics Inc.盘中异动 早盘急速上涨5.23%
Regulus Therapeutics Inc.盘中异动 股价大跌5.19%报1.28美元
市场透视 · 03-03
Regulus Therapeutics Inc.盘中异动 股价大跌5.19%报1.28美元
Regulus Therapeutics Inc.盘中异动 临近收盘股价大涨5.08%报1.35美元
市场透视 · 02-28
Regulus Therapeutics Inc.盘中异动 临近收盘股价大涨5.08%报1.35美元
Regulus Therapeutics Inc.盘中异动 下午盘股价大跌5.14%报1.29美元
市场透视 · 02-27
Regulus Therapeutics Inc.盘中异动 下午盘股价大跌5.14%报1.29美元
Regulus Therapeutics Inc.盘中异动 急速上涨5.12%
市场透视 · 02-26
Regulus Therapeutics Inc.盘中异动 急速上涨5.12%
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.51%
市场透视 · 02-21
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.51%
Regulus Therapeutics Inc.盘中异动 大幅拉升6.14%
市场透视 · 02-13
Regulus Therapeutics Inc.盘中异动 大幅拉升6.14%
Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.00%报1.14美元
市场透视 · 02-11
Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.00%报1.14美元
Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.51%报1.20美元
市场透视 · 02-07
Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.51%报1.20美元
Regulus Therapeutics Inc.盘中异动 早盘股价大涨22.76%
市场透视 · 02-04
Regulus Therapeutics Inc.盘中异动 早盘股价大涨22.76%
Regulus Therapeutics Inc.盘中异动 快速拉升5.87%
市场透视 · 02-03
Regulus Therapeutics Inc.盘中异动 快速拉升5.87%
Regulus Therapeutics Inc.盘中异动 早盘快速上涨6.19%
市场透视 · 01-30
Regulus Therapeutics Inc.盘中异动 早盘快速上涨6.19%
Regulus Therapeutics Inc.盘中异动 临近午盘大幅下挫5.04%
市场透视 · 01-28
Regulus Therapeutics Inc.盘中异动 临近午盘大幅下挫5.04%
加载更多
公司概况
公司名称:
Regulus Therapeutics Inc
所属市场:
NASDAQ
上市日期:
2012-10-04
主营业务:
Regulus Therapeutics Inc.于2007年9月6日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于发现和开发针对microRNA的一流药物,以治疗具有重大医疗需求的疾病。
发行价格:
4.00
{"stockData":{"symbol":"RGLS","market":"US","secType":"STK","nameCN":"Regulus Therapeutics Inc","latestPrice":7.98,"timestamp":1746043200000,"preClose":3.37,"halted":0,"volume":28494489,"hourTrading":{"tag":"盘后","latestPrice":7.9299,"preClose":7.98,"latestTime":"16:17 EDT","volume":14749,"amount":117400.329116,"timestamp":1746044259170},"delay":0,"floatShares":44874884,"shares":66243384,"eps":-0.822737,"marketStatus":"盘后交易","change":4.61,"latestTime":"04-30 16:17:55 EDT","open":7.985,"high":8.2,"low":7.7,"amount":224854694.3435427,"amplitude":0.148368,"askPrice":7.97,"askSize":150,"bidPrice":7.87,"bidSize":297,"shortable":3,"etf":0,"ttmEps":-0.822737,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1349323200000,"exchange":"NASDAQ","adjPreClose":3.37,"preHourTrading":{"tag":"盘前","latestPrice":7.98,"preClose":3.37,"latestTime":"09:29 EDT","volume":4771142,"amount":37380944.2958284,"timestamp":1746019799999},"postHourTrading":{"tag":"盘后","latestPrice":7.9299,"preClose":7.98,"latestTime":"16:17 EDT","volume":14749,"amount":117400.329116,"timestamp":1746044259170},"volumeRatio":13.408755,"optionData":{"bulkOrders":[{"symbol":"RGLS","call":false,"expireDate":1763701200000,"strike":"6.0","timestamp":1746033748860,"price":0.1,"volume":1441,"amount":14410,"type":"-"},{"symbol":"RGLS","call":false,"expireDate":1763701200000,"strike":"6.0","timestamp":1746040487297,"price":0.1,"volume":1063,"amount":10630,"type":"-"}]},"impliedVol":0.1354,"impliedVolPercentile":0.012},"requestUrl":"/m/hq/s/RGLS","defaultTab":"news","newsList":[{"id":"2532061934","title":"Jones Trading:下调Regulus Therapeutics评级,由买入调整至持有评级, 目标价由8.00美元调整至7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532061934","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532061934?lang=zh_cn&edition=full","pubTime":"2025-05-01 01:51","pubTimestamp":1746035517,"startTime":"0","endTime":"0","summary":"Jones Trading:下调Regulus Therapeutics(RGLS.US)评级,由买入调整至持有评级, 目标价由8.00美元调整至7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050101552794e93759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050101552794e93759&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ"],"gpt_icon":0},{"id":"2532061248","title":"加拿大投资银行集团:下调Regulus Therapeutics(RGLS.US)评级,由买入调整至持有评级, 目标价由28.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532061248","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532061248?lang=zh_cn&edition=full","pubTime":"2025-05-01 01:51","pubTimestamp":1746035517,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:下调Regulus Therapeutics(RGLS.US)评级,由买入调整至持有评级, 目标价由28.00美元调整至11.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/01015150064298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","RGLS"],"gpt_icon":0},{"id":"1138474240","title":"Regulus Therapeutics暴涨,诺华拟斥资至多17亿美元收购该公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1138474240","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138474240?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:45","pubTimestamp":1746020757,"startTime":"0","endTime":"0","summary":"该交易预计将于今年下半年完成。","market":"us","thumbnail":"https://static.tigerbbs.com/1766d484cdc0ac264f4ce34be3fa9fc2","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1766d484cdc0ac264f4ce34be3fa9fc2"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGLS"],"gpt_icon":0},{"id":"2531757873","title":"Regulus Therapeutics Inc.盘中异动 早盘大幅下挫5.01%报3.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531757873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531757873?lang=zh_cn&edition=full","pubTime":"2025-04-29 23:12","pubTimestamp":1745939537,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日23时12分,Regulus Therapeutics Inc.股票出现波动,股价大幅下跌5.01%。截至发稿,该股报3.32美元/股,成交量85.2455万股,换手率1.29%,振幅7.94%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.43%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429231217a6cd8378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429231217a6cd8378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4007","BK4139"],"gpt_icon":0},{"id":"2529931616","title":"Regulus Therapeutics Inc.盘中异动 快速拉升7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529931616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529931616?lang=zh_cn&edition=full","pubTime":"2025-04-24 21:30","pubTimestamp":1745501446,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日21时30分,Regulus Therapeutics Inc.股票出现异动,股价急速上涨7.84%。截至发稿,该股报2.75美元/股,成交量8.3019万股,换手率0.13%,振幅5.88%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504242130469743a712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504242130469743a712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","BK4007","LENZ"],"gpt_icon":0},{"id":"2529668146","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.84%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529668146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529668146?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:30","pubTimestamp":1745415028,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时30分,Regulus Therapeutics Inc.股票出现异动,股价大幅拉升5.84%。截至发稿,该股报2.46美元/股,成交量4.5593万股,换手率0.07%,振幅1.09%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Ensysce Biosciences, Inc.、Rezolute, Inc.、Glycomimetics, Inc.涨幅较大,Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃,换手率分别为2736.19%、17.21%、6.61%,振幅较大的相关个股有Biohaven Ltd.、Candel Therapeutics, Inc.、Igc Pharma, Inc.,振幅分别为6.38%、5.60%、4.90%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321302897423191&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321302897423191&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","RGLS"],"gpt_icon":0},{"id":"2529846587","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529846587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529846587?lang=zh_cn&edition=full","pubTime":"2025-04-22 22:18","pubTimestamp":1745331529,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日22时18分,Regulus Therapeutics Inc.股票出现异动,股价急速上涨5.42%。截至发稿,该股报2.12美元/股,成交量10.9651万股,换手率0.17%,振幅5.22%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.38%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422221849a46294be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422221849a46294be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2527941773","title":"Regulus Therapeutics Inc.盘中异动 早盘急速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527941773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527941773?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:39","pubTimestamp":1744724359,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时39分,Regulus Therapeutics Inc.股票出现波动,股价大幅拉升5.23%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Mural Oncology Plc、Verve Therapeutics, Inc.、Precision Biosciences, Inc.涨幅较大,Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃,换手率分别为461.65%、208.81%、82.51%,振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc、Nextcure, Inc.,振幅分别为80.08%、52.43%、38.78%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041521391994d62cd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041521391994d62cd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","RGLS"],"gpt_icon":0},{"id":"2516668804","title":"Regulus Therapeutics Inc.盘中异动 股价大跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516668804?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:48","pubTimestamp":1741031286,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时48分,Regulus Therapeutics Inc.股票出现异动,股价大幅下挫5.19%。截至发稿,该股报1.28美元/股,成交量6.9804万股,换手率0.11%,振幅5.19%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.70%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040348079637f2dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040348079637f2dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"gpt_icon":0},{"id":"2516617301","title":"Regulus Therapeutics Inc.盘中异动 临近收盘股价大涨5.08%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516617301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516617301?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:54","pubTimestamp":1740776057,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时54分,Regulus Therapeutics Inc.股票出现异动,股价急速上涨5.08%。截至发稿,该股报1.35美元/股,成交量12.0953万股,换手率0.18%,振幅5.20%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.77%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010454179896c80c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010454179896c80c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"gpt_icon":0},{"id":"2514332980","title":"Regulus Therapeutics Inc.盘中异动 下午盘股价大跌5.14%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514332980?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:20","pubTimestamp":1740687621,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时20分,Regulus Therapeutics Inc.股票出现异动,股价快速下挫5.14%。截至发稿,该股报1.29美元/股,成交量11.7717万股,换手率0.18%,振幅9.37%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.39%。其相关个股中,Pepgen Inc.、Ibio, Inc.、Xortx Therapeutics Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃,换手率分别为1923.58%、364.70%、192.31%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation,振幅分别为86.14%、67.32%、55.84%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022804202198954fe4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022804202198954fe4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RGLS"],"gpt_icon":0},{"id":"2514863962","title":"Regulus Therapeutics Inc.盘中异动 急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514863962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514863962?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:14","pubTimestamp":1740590061,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时14分,Regulus Therapeutics Inc.股票出现波动,股价快速上涨5.12%。截至发稿,该股报1.34美元/股,成交量8.3862万股,换手率0.13%,振幅5.12%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.05%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270114219893c99a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270114219893c99a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2513294174","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513294174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513294174?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:47","pubTimestamp":1740152856,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时47分,Regulus Therapeutics Inc.股票出现波动,股价大幅上涨5.51%。截至发稿,该股报1.34美元/股,成交量8.5957万股,换手率0.13%,振幅4.72%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221234736abd7c0a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221234736abd7c0a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2511711375","title":"Regulus Therapeutics Inc.盘中异动 大幅拉升6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511711375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511711375?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:37","pubTimestamp":1739475436,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时37分,Regulus Therapeutics Inc.股票出现波动,股价快速拉升6.14%。截至发稿,该股报1.21美元/股,成交量9.2638万股,换手率0.14%,振幅7.02%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.06%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140337169621f6bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140337169621f6bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2510380575","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380575?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:40","pubTimestamp":1739284853,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时40分,Regulus Therapeutics Inc.股票出现异动,股价急速下跌5.00%。截至发稿,该股报1.14美元/股,成交量9688股,换手率0.01%,振幅5.42%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.31%。其相关个股中,Dominari Holdings Inc.、Ocean Biomedical, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2238.82%、586.82%、229.16%,振幅较大的相关个股有Ocean Biomedical, Inc.、In8Bio, Inc.、Dominari Holdings Inc.,振幅分别为32.43%、31.80%、29.38%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224053961f498d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224053961f498d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2509744754","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.51%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509744754?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:34","pubTimestamp":1738938894,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时34分,Regulus Therapeutics Inc.股票出现异动,股价急速下挫5.51%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Engene Holdings Inc C/Wts 31/10/2028 Cl A涨幅较大,Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Aditxt, Inc.较为活跃,换手率分别为1185.99%、44.56%、34.65%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为130.43%、31.61%、20.91%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223454987dae09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223454987dae09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2508745747","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨22.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508745747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508745747?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:36","pubTimestamp":1738679817,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时36分,Regulus Therapeutics Inc.股票出现异动,股价急速上涨22.76%。截至发稿,该股报1.51美元/股,成交量80.6906万股,换手率1.23%,振幅12.20%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大,Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃,换手率分别为1001.92%、714.21%、190.95%,振幅较大的相关个股有Azitra Inc、Invivyd, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为35.91%、21.70%、21.03%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223657abc22966&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223657abc22966&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2508144300","title":"Regulus Therapeutics Inc.盘中异动 快速拉升5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508144300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508144300?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593303,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分,Regulus Therapeutics Inc.股票出现异动,股价快速拉升5.87%。截至发稿,该股报1.06美元/股,成交量13.275万股,换手率0.20%,振幅4.87%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.36%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223503abc107d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223503abc107d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2507562191","title":"Regulus Therapeutics Inc.盘中异动 早盘快速上涨6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507562191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507562191?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:35","pubTimestamp":1738247723,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时35分,Regulus Therapeutics Inc.股票出现波动,股价快速拉升6.19%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Alterity Therapeutics Limited、Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited涨幅较大,Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃,换手率分别为730.20%、129.89%、110.20%,振幅较大的相关个股有Kazia Therapeutics Limited、Tectonic Therapeutic, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ,振幅分别为28.25%、24.49%、21.31%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302235239876b21d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302235239876b21d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2507546277","title":"Regulus Therapeutics Inc.盘中异动 临近午盘大幅下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507546277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507546277?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:59","pubTimestamp":1738083573,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时59分,Regulus Therapeutics Inc.股票出现波动,股价急速跳水5.04%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.13%。其相关个股中,Silexion Therapeutics Corp、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为4554.51%、3431.98%、268.84%,振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Silexion Therapeutics Corp,振幅分别为236.17%、122.16%、89.64%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012900593398757bc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012900593398757bc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RGLS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regulusrx.com","stockEarnings":[{"period":"1week","weight":0.4526},{"period":"1month","weight":0.948},{"period":"3month","weight":2.4742},{"period":"6month","weight":1.3082},{"period":"1year","weight":0.3373},{"period":"ytd","weight":1.1329}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regulus Therapeutics Inc.于2007年9月6日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于发现和开发针对microRNA的一流药物,以治疗具有重大医疗需求的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":-0.043674},{"month":2,"riseRate":0.384615,"avgChangeRate":0.02347},{"month":3,"riseRate":0.538462,"avgChangeRate":0.105895},{"month":4,"riseRate":0.307692,"avgChangeRate":0.017893},{"month":5,"riseRate":0.583333,"avgChangeRate":0.084394},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.119338},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.130856},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.042258},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.004778},{"month":10,"riseRate":0.166667,"avgChangeRate":0.026008},{"month":11,"riseRate":0.461538,"avgChangeRate":0.057414},{"month":12,"riseRate":0.384615,"avgChangeRate":0.049982}],"exchange":"NASDAQ","name":"Regulus Therapeutics Inc","nameEN":"Regulus Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regulus Therapeutics Inc,RGLS,Regulus Therapeutics Inc股票,Regulus Therapeutics Inc股票老虎,Regulus Therapeutics Inc股票老虎国际,Regulus Therapeutics Inc行情,Regulus Therapeutics Inc股票行情,Regulus Therapeutics Inc股价,Regulus Therapeutics Inc股市,Regulus Therapeutics Inc股票价格,Regulus Therapeutics Inc股票交易,Regulus Therapeutics Inc股票购买,Regulus Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}